Keywords for AIIB's first decade: multilateral cooperation, mutual connectivity, extensive consultation, and joint contribution
BEIJING, Dec. 25, 2025 /PRNewswire/ -- A news report from China.org.cn on AIIB's first decade: Keywords for AIIB's first decade: multilateral cooperation, mutual connectivity, extensive consultation, and joint contribution In a primary school...
China's First Domestic Anti-CTLA-4 Monoclonal Antibody, Innovent's TABOSUN® (Ipilimumab N01 Injection) Received NMPA Approval
TABOSUN® (ipilimumab N01 injection) has been approved in combination with TYVYT® (sintilimab injection) for the neoadjuvant treatment of patients with stage IIB-III resectable microsatellite instability-high or mismatch repair deficient (MSI-H/dMMR)...
Elong Power Holding Limited Announces Effective Date of Reverse Stock Split
BEIJING, Dec. 23, 2025 /PRNewswire/ -- Elong Power Holding Limited ("Elong Power" or the "Company") (Nasdaq: ELPW), a provider of high power battery technologies for commercial and specialty alternative energy vehicles and energy storage systems,...
Three More Coway Airmega Air Purifiers Approved by Sensitive Choice for Australians with Allergies and Asthma
- Three additional Coway Airmega models have been recognised by the National Asthma Council Australia for their potential to benefit those living with asthma and allergies. SYDNEY, Dec. 23, 2025 /PRNewswire/ -- For the millions of Australians living...
Guardant Health Japan receives regulatory approval of Guardant360® CDx liquid biopsy as companion diagnostic for imlunestrant in metastatic or recurrent breast cancer previously treated with endocrine therapy
Guardant360® CDx is the first companion diagnostic to be approved in Japan to identify ESR1 mutations in patients with hormone receptor-positive, HER2-negative breast cancer for treatment with imlunestrant TOKYO, Dec. 22, 2025 /PRNewswire/ --...
Nanto City and GigaStream Toyama Conclude Agreement for the Development of Japan's Largest Data Center Cluster (3.1GW) including the acquisition of Phase 1 Land to Support 400MW
— Realizing Japan's "Third Major Data Center Cluster," Following Tokyo and Osaka — NANTO, Japan, Dec. 19, 2025 /PRNewswire/ -- Nanto City (Mayor Mikio Tanaka) and GigaStream Toyama K.K. (1-chome Honmachi, Nanto City; Representative Director: Daniel...
Nature | Two Phase 3 Clinical Results of Mazdutide (GLP-1/GCG Dual Receptor Agonist) in Chinese Adults with Type 2 Diabetes Have Been Back-to-Back Published in Nature
SAN FRANCISCO and SUZHOU, China, Dec. 18, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...
FUTURE FUND OMAN COMMITS $1.2 BILLION AS $5.2 BILLION INVESTMENT PROGRAM ACCELERATES ECONOMIC DIVERSIFICATION
MUSCAT, Oman, Dec. 18, 2025 /PRNewswire/ -- Future Fund Oman announced record activity in 2025, approving 141 projects this year and lifting total commitments to $1.2 billion as the fund accelerates Oman's economic diversification agenda....
Antengene Expands XPOVIO® Indications in Malaysia with Approval in Diffuse Large B-cell Lymphoma
SHANGHAI and HONG KONG, Dec. 17, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class...
Paranovus Entertainment Technology Limited Announces 1-For-100 Reverse Share Split
NEW YORK, Dec. 16, 2025 /PRNewswire/ -- Paranovus Entertainment Technology Limited (NASDAQ: PAVS), today announced that it will effect a reverse share split of its outstanding Class A ordinary shares, par value $0.01 per share (the "Class A Ordinary...